Regulatory Strategy & Agency Readiness

• FDA regulatory pathway assessment

• ODD, Pre-IND, IND, BLA and Q-Sub strategy

• Regulatory gap analysis

• Agency briefing documents and meeting preparation

Product Development Strategy

• Integrated product development roadmap

• CMC and technical strategy coordination

• Submission enabling strategy, planning and execution

• Risk assessment and milestone planning

Strategic Project Leadership

• Cross functional coordination across scientific, regulatory, and business teams

• Strategic program leadership during key development stages

• Executive level advisory support for complex development programs

• Biopharmaceutical development

• Molecular diagnostics and medical devices

• Cell culture and bioprocess development

• Emerging biotechnology platforms

EssenScale operates through a network of experienced biotechnology and regulatory professionals, assembled based on the specific needs of each project.

The team includes specialists with backgrounds in:

• CMC and bioprocess development

• Regulatory strategy and FDA interactions

• Nonclinical development and toxicology

• Biotechnology product development

• Medical devices and diagnostics

• Scientific and technical due diligence

This flexible structure enables EssenScale to deploy project specific expert teams tailored to each client’s technology, development stage, and regulatory objectives.

EssenScale works with clients through flexible structures:

• Project-based consulting engagements

• Strategic advisory retainers

• Fractional executive leadership roles

• Specialized regulatory and development assessments